Can multicentre urodynamic studies provide high quality evidence for the clinical effectiveness of urodynamics? ICI-RS 2019.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
07 2020
Historique:
received: 11 09 2019
accepted: 20 12 2019
pubmed: 22 1 2020
medline: 22 12 2020
entrez: 22 1 2020
Statut: ppublish

Résumé

Lower urinary tract (LUT) function can be investigated by urodynamic studies (UDS) to establish underlying functional abnormalities in the LUT. A multicentre registry could present an opportunity to improve the scientific evidence base for UDS. During the International Consultation on Incontinence Research Society (ICI-RS) meeting in Bristol, United Kingdom 2019, an expert panel discussed the potential of a multicentre urodynamic registry to improve the quality of urodynamic output. the potential importance of a multicentre urodynamic registry, parameter inclusion, quality control, and pitfalls during a registry roll-out were reviewed and discussed. The clinical utility, evaluation, and effectiveness of UDS remain poorly defined due to a lack of high quality evidence and large study populations. Therefore, the ICI-RS proposes formation of a urodynamic panel for future roll-out of a registry. The inclusion of basic parameters was discussed and the essential parameters were defined as well as the potential pitfalls of a registry roll-out. The discussion and recommendations in this paper form the base for future urodynamic registry development.

Identifiants

pubmed: 31961959
doi: 10.1002/nau.24280
pmc: PMC7497217
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S30-S35

Informations de copyright

© 2020 The Authors. Neurourology and Urodynamics published by Wiley Periodicals, Inc.

Références

Neurourol Urodyn. 2004;23(3):280-1
pubmed: 15098227
Urology. 2013 Sep;82(3):560-4
pubmed: 23876577
PLoS One. 2017 Sep 8;12(9):e0183667
pubmed: 28886607
Neurourol Urodyn. 2016 Sep;35(7):809-12
pubmed: 26061435
Neurourol Urodyn. 2013 Mar;32(3):301-2
pubmed: 23023985
Neurourol Urodyn. 2017 Jun;36(5):1243-1260
pubmed: 27917521
Obstet Gynecol. 2006 Aug;108(2):315-23
pubmed: 16880301
Clin Physiol. 1985 Oct;5(5):417-23
pubmed: 3902333
Eur Urol Focus. 2020 Jan 15;6(1):137-145
pubmed: 30061075
N Engl J Med. 2012 May 24;366(21):1987-97
pubmed: 22551104
Neurourol Urodyn. 2020 Jul;39 Suppl 3:S30-S35
pubmed: 31961959
Curr Opin Urol. 2017 Jul;27(4):375-379
pubmed: 28441270
Neurourol Urodyn. 2002;21(2):167-78
pubmed: 11857671

Auteurs

Kevin Rademakers (K)

Department of Urology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.

Andrew Gammie (A)

Department of Urology, Bristol Urological Institute, Southmead Hospital, Bristol, UK.

Habiba Yasmin (H)

Department of Urology, University College London Hospital, London, UK.

Linda Cardozo (L)

Department of Urogynaecology, King's College Hospital, London, UK.

Tamsin Greenwell (T)

Department of Urology, University College London Hospital, London, UK.

Christopher Harding (C)

Department of Urology, Freeman hospital, Newcastle Upon-Tyne, UK.

Ruth Kirschner-Hermanns (R)

Department of Urology/Neuro-Urology, University Clinic, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Department of Neuro-Urology, Neurological Rehabilitation Center Godeshoehe e.V., Bonn, Germany.

Tom Marcelissen (T)

Department of Urology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.

Enrico Finazzi-Agro (E)

Department of Experimental Medicine and Surgery, Department of Surgery, Policlinico Tor Vergata, University of Rome "Tor Vergata" and Urology Unit, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH